Carisoprodol (Soma): a new and cautious perspective on an old agent.

Article Details

Citation
Copy to clipboard

Littrell RA, Hayes LR, Stillner V

Carisoprodol (Soma): a new and cautious perspective on an old agent.

South Med J. 1993 Jul;86(7):753-6.

PubMed ID
8322081 [ View in PubMed
]
Abstract

Carisoprodol (Soma, others) is a commonly prescribed, noncontrolled, skeletal muscle relaxant whose active metabolite is meprobamate. Patients for whom carisoprodol is prescribed are at risk for meprobamate dependence; several such cases have been reported. Toxicity and withdrawal associated with the use of meprobamate is high and has led to abandonment of this agent in clinical practice. Because carisoprodol possesses the same risks it should be avoided when possible, and it should be given schedule IV controlled substance status.

DrugBank Data that Cites this Article

Drugs